In critically ill patients, the progression from Systemic Inflammatory Response Syndrome (SIRS) to Multi-Organ Dysfunction Syndrome (MODS) is associated with a poor prognosis. Given this challenge, what is the primary goal in the management of these patients to improve their overall prognosis?